Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening prostate cancer care, support, and outcomes for veterans. Taking place ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Prostate Cancer Progress: Novel Immunotherapy Agent Enoblituzumab Shows Potential in Clinical Trials for High-Risk Patients NEW YORK, NY, USA, June 22, 2023 ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

Charities fought for more than three years to end a postcode lottery in access to the drug.

ZERO Prostate Cancer welcomes Marcus Blassingame, one of the fashion industry's most influential celebrity stylists, as the newest ambassador. Known for shaping the visual identities of stars across ...

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...